ABT
ABBOTT LABORATORIES
Healthcare • CIK 0000001800
Loading...
Market Cap
$178.83B
P/E (TTM)
28.4x
Rev Growth (TTM)
+6.6%
Net Margin (TTM)
14.0%
FCF Yield (TTM)
4.1%
FCF Margin (TTM)
16.3%
Filings your agent reads
Primary-source SEC disclosures, read end-to-end — every figure traceable to its filing.
CALLApr 2026Earnings calltranscript
10-QQ1 20262026-04-29source
8-KApr 20262026-04-27source
8-KApr 20262026-04-17source
8-KEarnings2026-04-16source
8-KMar 20262026-03-23source
Point your agent at ABT and it navigates these the same way — citing each number back to the filing.
Cash Flow Health
Free Cash Flow8/8 positive
TTM$7.4B
Q1 '26
$916M-65%
Q4 '25
$2.6B+15%
FCF Margin
TTM16.3%
Q1 '268.2%-64%
Sector: 0.0%Top 10%
OCF Margin21.0%
OCF/NI1.50x
CapEx Coverage4.5x
FCF Yield4.1%
FCF Growth (2Y)+3%
Cash Conversion Cycle
189 days
DSO: 64+DIO: 125−DPO: 0
Capital Allocation & Returns
Balanced
Total Shareholder YieldTTM
TTM2.8%
Div Yield2.3%
+Buyback (TTM)0.4%
Balancing returns with reinvestment
Dividend & Payout Metrics
Dividend Yield (TTM)2.3%
FCF Payout Ratio56.8%
Free Cash Flow (TTM)$7.4B
Stock Repurchases (TTM)$793.0M
Capital Return / FCF67.5%
Est. Dividends Paid (TTM)$4.2B
Shows how management rewards shareholders
Operational Efficiency & Returns
Return on Invested CapitalTTM
8.9%
Stable
-0.1% YoY-4.7%
P25MedianP75
75th pctl (med: -0.0%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
13.2%
8Q: 14.2%
Asset Turnover
0.51x
8Q: 0.54x
Leverage (1+D/E)
1.65x
D/E: 0.65x
DuPont: 11.2% ≈ 8.9% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
3.89x
8Q:3.98x
-31.5%
Invested Cap Turn
0.83x
8Q:0.85x
-3.5%
CapEx Intensity
3.8%
8Q:4.1%
CapEx/Depreciation
0.66x
Depreciation Rate Trend
⚠ Declining -2.2%
Asset-based ROIC formula
Valuation Analysis
Fair Value
Price-to-EarningsTTM
28.4x
Volatile
8Q: 136.9x+4144%
Multiple expansion without fundamental improvement
High PEG ratio (4.3x) suggests expensive for growth
Valuation Lenses
Earnings
28.4x
vs – sector
Cash Flow
25.3x
EV/FCF vs –
Growth-Adj
4.3xPEG
Expensive for growth
Quality-Adj
3.2P/E per %ROIC
ROIC: 8.9%
Shareholder Returns
Dividend
2.3%
Buyback
0.4%
Total Yield
2.8%
Market Cap$178.83B
EV$186.81B
Multi-angle valuation analysis with sector context
Business Quality & Moat
Overall Quality Score
77/100
High Quality
Composite score: Returns (40%) + Consistency (30%) + Earnings Quality (30%)
Returns on Capital
Return on Equity (ROE)Above Avg
12.3%
8Q:–
Return on Invested Capital (ROIC)Top 25%
8.9%
8Q:–
-4.7%
vs Sector:-0.0%
DuPont Analysis (ROIC = NOPAT Margin × Asset Turnover)
NOPAT Margin: 13.2%
Asset Turnover: 0.51x
Earnings Quality
Cash Conversion
1.50x
OCF / Net Income ✓
FCF Consistency
–
Positive quarters
Competitive Moat Indicators
Pricing Power
Gross Margin56.3%
Capital Efficiency
Invested Capital Turnover0.83x
Working Capital
Cash Conversion Cycle189 days
Growth Quality & Momentum
Moderate Growth
Growth Quality Score
58/100
Growth 40%
Margins 30%
FCF 20%
Consistency 10%
Growth Rates
Revenue Growth YoY
6.6%
OpInc Growth YoY
-20.6%
EPS Growth YoY
-53.0%
FCF 3Y CAGR
2.6%
Margin Quality & Sustainability
Moderate
Profitability Cascade
Gross
56.3%
Operating
17.1%
Top 25% in sector
Net
14.0%
Margins Unknown
Earnings Quality Signals
SBC / Revenue
—
FCF vs Net Gap
+2.4 pts
FCF: 16.3% | Net: 14.0%
Quality = stability + cash conversion + low dilution
Balance Sheet & Solvency
Adequate
Net Debt / EBITDA
–Net Debt: $26.75B
Interest Coverage
–
Leverage Metrics
Debt-to-Equity
0.65x
Balance sheet risk & solvency analysis